Growth Metrics

Eli Lilly (LLY) Inventory (2016 - 2026)

Eli Lilly filings provide 18 years of Inventory readings, the most recent being $14.5 billion for Q1 2026.

  • On a quarterly basis, Inventory rose 56.04% to $14.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $14.5 billion, a 56.04% increase, with the full-year FY2025 number at $13.7 billion, up 81.1% from a year prior.
  • Inventory hit $14.5 billion in Q1 2026 for Eli Lilly, up from $13.7 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14.5 billion in Q1 2026 to a low of $3.8 billion in Q3 2022.
  • Median Inventory over the past 5 years was $6.1 billion (2024), compared with a mean of $7.3 billion.
  • Biggest five-year swings in Inventory: decreased 1.95% in 2022 and later surged 81.1% in 2025.
  • Eli Lilly's Inventory stood at $4.3 billion in 2022, then surged by 33.95% to $5.8 billion in 2023, then surged by 31.46% to $7.6 billion in 2024, then surged by 81.1% to $13.7 billion in 2025, then grew by 5.71% to $14.5 billion in 2026.
  • The last three reported values for Inventory were $14.5 billion (Q1 2026), $13.7 billion (Q4 2025), and $12.2 billion (Q3 2025) per Business Quant data.